PR Newswire Clinical TrialsOriginal article
Spark Biomedical and Feinstein Institutes Publish First-in-Human Study Demonstrating Non-Invasive tAN® Technology Enhances Platelet Function
Data ReadoutpositivetAN®Positive
AI Analysis
Summary
Spark Biomedical and Feinstein Institutes published a first-in-human study demonstrating that the wearable auricular neurostimulation platform tAN® can enhance platelet function. The research was published in Bioelectronic Medicine.
Clinical Trial Data
Phase
Phase_1
Primary Endpoint
Met
Outcome Details
First-in-human study demonstrates non-invasive auricular neurostimulation technology enhances platelet function
Importance:5/10
Sentiment:
0.70
clinical_trialfirst_in_humanwearable_technologyneurostimulationplatelet_functionpublication
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on July 13, 2026 1:00 PM